Skip to main content Help with accessibility Skip to main navigation

June 2023 updates to the website

The website has now been updated following the June meeting of the LSCMMG

Levetiracetam (Keppra®) prescribing: bioequivalence and antiepileptic drugs - position statement and SOP

Antihistamine position statement (interim LSCMMG guidance)

Gluten free products position statement (interim LSCMMG guidance) 

Lipid Management Pathway for Primary Prevention of Cardiovascular Disease (CVD)

Primary Care Management of Menopause - guideline and product relative cost list